Skip to main content
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Home
Browse by Topic
Special Series
Conference Correspondent
NSCLC 2022 Midyear Review
Supplements
Special Issues
Multimedia
Video Library
Rapid Reactions
Subscribe
Melanoma/Skin Cancer
Personalized Neoadjuvant Immunotherapy Combinations Improve Outcomes in Stage III Melanoma
By
Wayne Kuznar
Melanoma/Skin Cancer
,
Web Exclusives
Read More ›
Talimogene Laherparepvec (T-VEC) as Cancer Immunotherapy
By
Sachin Jhawar, MD
;
Sharad Goyal, MD
;
Praveen K. Bommareddy, MS
;
Andrew Zloza, MD
;
Howard L. Kaufman, MD, FACS
Melanoma/Skin Cancer
Read More ›
Treatment Strategies for
BRAF
Wild-Type Metastatic Melanoma
By
Zahra Rahman, DO
;
Ahmad Tarhini, MD, PhD
Melanoma/Skin Cancer
Read More ›
Melanoma: A New Frontier in Personalized Medicine
By
Yana G. Najjar
;
John M. Kirkwood
Melanoma/Skin Cancer
Read More ›
Combination Checkpoint Blockade—It Is the New Standard for All Patients
By
Steven O’Day, MD
;
Jeffrey Weber, MD, PhD
Melanoma/Skin Cancer
Read More ›
A Role for Intralesional Monotherapy in Melanoma: Debate
Melanoma/Skin Cancer
Read More ›
Pembrolizumab Combination Shows Robust Antitumor Activity
By
Christine Anderson
Melanoma/Skin Cancer
Read More ›
Oral Nicotinamide Prevents Common Skin Cancers
Melanoma/Skin Cancer
Read More ›
Case: “Difficult-to-Operate” Basal Cell Carcinoma
By
Sanjiv S. Agarwala, MD
Melanoma/Skin Cancer
Read More ›
NRAS Mutation Impacts Response to Immune Therapies in Melanoma
Melanoma/Skin Cancer
Read More ›
Page 1 of 3
1
2
3